2.7K(top 8%)
articles
52.1K(top 8%)
citations
426(top 8%)
★★ articles
15(top 7%)
★★★ articles
2.4(top 22%)
Avg IF
93(top 8%)
H-Index
163(top 7%)
G-Index
888
journals

Most Cited Articles of Concord Repatriation General Hospital in 2012

TitleJournalYearCitations
Vitamin D and health in adults in Australia and New Zealand: a position statementMedical Journal of Australia2012213
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoringAntimicrobial Agents and Chemotherapy2012206
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trialSupportive Care in Cancer2012152
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentrationAntimicrobial Agents and Chemotherapy2012148
The scavenger endothelial cell: a new player in homeostasis and immunityAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology2012135
Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: a before and after studyPLoS Medicine2012121
Electrospun synthetic human elastin:collagen composite scaffolds for dermal tissue engineeringActa Biomaterialia2012120
Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoringAntimicrobial Agents and Chemotherapy2012120
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthmaThorax2012114
Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in miceCancer Research2012100
Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)Journal of Neurology, Neurosurgery and Psychiatry201297
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerAnnals of Oncology201297
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesotheliomaJournal of Thoracic Oncology201295
Review article: Ulcerative colitis, smoking and nicotine therapyAlimentary Pharmacology and Therapeutics201291
The true cost of burnBurns201290
Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vesselsBlood201280
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention studyOsteoporosis International201273
Short and long sleep duration are associated with prevalent cardiovascular disease in Australian adultsJournal of Sleep Research201272
Custom-fit total knee arthroplasty: our initial experience in 32 kneesJournal of Arthroplasty201269
A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after strokeClinical Rehabilitation201249
Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptidesClinical Pharmacology and Therapeutics201249
Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgeryHeart201245
Prognostic communication preferences of migrant patients and their relativesPsycho-Oncology201243
The ticking time-bomb of asbestos: its insidious role in the development of malignant mesotheliomaCritical Reviews in Oncology/Hematology201242
Interventions for smoking cessation in Indigenous populationsThe Cochrane Library201241